Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mira Harrison-Woolrych

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Pharmacoepidemiology and Drug Safety|July 6, 2010
Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New ZealandMira Harrison-Woolrych, Janelle Ashton
Contraception|March 29, 2005
Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in AustraliaMira Harrison-Woolrych, Richard Hill
Drug Safety|March 14, 2020
ISoP Fellowships: Recognising Contributions to the Goals of ISoPDeirdre McCarthy, Mira Harrison-Woolrych
BMJ Sexual & Reproductive Health|August 28, 2023
Improving access to medicines for early medical abortion: learning from experiences of medicines licensing and service deliverySam Rowlands, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 26, 2015
New study supports MHRA advice on combined oral contraceptivesMira Harrison-Woolrych, Jane Woolley
International Journal of Clinical Pharmacy|August 4, 2018
The role and strategy of ISoP in global pharmacovigilanceSten Olsson, Mira Harrison-Woolrych
European Journal of Clinical Pharmacology|December 13, 2012
Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring ProgrammeMing Tan, Mira Harrison-Woolrych
Drug Safety|September 15, 2012
How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug MonitoringPriya Bahri, Mira Harrison-Woolrych
The Journal of Family Planning and Reproductive Health Care|March 11, 2003
Progestogen-only emergency contraception and ectopic pregnancyMira Harrison-Woolrych, Jane Woolley
Drug Safety|October 16, 2012
Focusing on risk communication about medicines: why now?Priya Bahri, Mira Harrison-Woolrych
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Pharmacoepidemiology and Drug Safety|July 6, 2010
Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New ZealandMira Harrison-Woolrych, Janelle Ashton
Contraception|March 29, 2005
Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in AustraliaMira Harrison-Woolrych, Richard Hill
Drug Safety|March 14, 2020
ISoP Fellowships: Recognising Contributions to the Goals of ISoPDeirdre McCarthy, Mira Harrison-Woolrych
BMJ Sexual & Reproductive Health|August 28, 2023
Improving access to medicines for early medical abortion: learning from experiences of medicines licensing and service deliverySam Rowlands, Mira Harrison-Woolrych
BMJ (Clinical Research Ed.)|June 26, 2015
New study supports MHRA advice on combined oral contraceptivesMira Harrison-Woolrych, Jane Woolley
International Journal of Clinical Pharmacy|August 4, 2018
The role and strategy of ISoP in global pharmacovigilanceSten Olsson, Mira Harrison-Woolrych
European Journal of Clinical Pharmacology|December 13, 2012
Memory impairment associated with varenicline: a case series from the New Zealand Intensive Medicines Monitoring ProgrammeMing Tan, Mira Harrison-Woolrych
Drug Safety|September 15, 2012
How to improve communication for the safe use of medicines?: Discussions on social marketing and patient-tailored approaches at the annual meetings of the WHO Programme for International Drug MonitoringPriya Bahri, Mira Harrison-Woolrych
The Journal of Family Planning and Reproductive Health Care|March 11, 2003
Progestogen-only emergency contraception and ectopic pregnancyMira Harrison-Woolrych, Jane Woolley
Drug Safety|October 16, 2012
Focusing on risk communication about medicines: why now?Priya Bahri, Mira Harrison-Woolrych
Pageof 5